REMS Communications Need FDA Logo To Boost Doctors’ Attention, Advisors Say
Risk Communication Advisory Committee suggests that adding the agency imprimatur to REMS materials may help distinguish it from promotional mail and ensure providers read the communications.
You may also be interested in...
Chantix's Boxed Warning: Will A Positive Vote Justify A Negative Outcome?
FDA could use advisory committee members' comments to maintain the smoking cessation drug's boxed warning, even though they voted to remove it.
FDA Logo Modernization Aims For Uniform 'Look And Feel'
Changes will eliminate more distinctive graphics for individual centers to help make agency communications more consistent.
REMS Standardization Could Help Opioid Education Efforts
FDA hopes to begin accepting Risk Evaluation and Mitigation Strategy documents in structured product labeling format later this year.